Prostate Cancer: Dissatisfaction With Current Diagnostics Drives Interest In Innovation

Prostate cancer remains one of the most deadly and perplexing of the diseases that affect men. It is the second most common type of cancer in men, as well as the second leading cause of cancer death, but the problem goes beyond the mortality rate. Experts note that the disease is nearly 100% survivable if caught early, and aggressive treatments such as radical prostatectomies and radiation therapies can be effective in cancers in the later stages. The problem is, despite advances in treatment technology, the industry is still lacking a way to more accurately diagnose the severity of a patient’s cancer, and that has led to overtreatment from physicians who fear missing something the tests do not show.

These factors make better diagnostic testing tools a top priority for everyone involved, including payors looking for new technologies that could eliminate the need for those expensive, aggressive treatments.